RINVOQ 45 mg prolonged-release tablets

Company
AbbVie Limited
Active Ingredient
Strength
  • 45 mg
Dosage Form
Prolonged-release tablet
Legal Category
A - prescription, may not be renewed
Last Updated
25/09/2026

Loading the document

AbbVie Limited

Citywest Business Campus, Dublin 24, Ireland